comparemela.com

Latest Breaking News On - Edwardj gane - Page 1 : comparemela.com

AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024

/PRNewswire/ AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced the.

New zealandUnited statesOwen wangEdwardj ganeAusper biopharma co ltdInternational liver congressFirst hospital of jilin universityPrnewswire ausperbio therapeutics incUniversity of aucklandBio therapeuticsEuropean associationFirst hospitalJilin university

Assembly Biosciences to Introduce New Small Molecule Liver-Focused Interferon-α Receptor Agonist Research Program in Webcast on July 26, 2022

Assembly Bio leadership team will be joined by Professor Edward J. Gane, MBCHB, MD, FRACP, MNZM, an internationally-recognized hepatologist, and authority and investigator in hepatitis clinical. | June 21, 2022

New zealandJohn mchutchisonShannon ryanWilliam delaneyEdwardj ganeViral hepatitis to expand the company portfolioAssembly bio expertise in small moleculesAlliance managementReceptor agonist research programAssembly biosciencesAssembly biosciences incSam brown incExchange commissionSecurities exchangeRisk factors in assembly bioCorporate affairs

Arbutus to Present Seven Scientific Posters at EASL International Liver Congress™ 2022 - Press Release

Conference Call & Webcast to discuss new data being presented at EASL ILC 2022 scheduled for June 27, 2022 at 8:00 am ETWARMINSTER, Pa., June 07,

United kingdomUnited statesCity ofLisam caperelliShariec ganchuaEdwardj ganeN acetylgalactosamine galnacFung yuenWilliamh collierArbutus biopharma corporationSecurities exchangeWorld health organizationInternational liver congressConference callEuropean associationAbstract number

vimarsana © 2020. All Rights Reserved.